feed,title,long_url,short_url
Benzinga,Updated Analysis Show Seagen's Tukysa Extended Median OS to Two Years with Benefits Maintained in Breast Cancer,https://benzinga.com/general/biotech/21/06/21405164/updated-analysis-show-seagens-tukysa-extended-median-os-to-two-years-with-benefits-maintained-in-,https://j.mp/3uOySX0
